ELV
Elevance Health Inc.
NYSE · Healthcare · Medical - Healthcare Plans · US
$407.50
−1.76%Aug 17, 2026, 10:06 UTC
Barden Capital Management Inc. acquired a new stake in Elevance Health, Inc. during the second quarter, purchasing 1,609 shares valued at approximately $622,000.
Source:Aug 17, 2026, 08:55 UTC
Avise Financial Cooperative Inc. acquired a new stake in Elevance Health, Inc. (NYSE: ELV), purchasing 1,633 shares valued at approximately $632,000, as disclosed in its Form 13F filing with the SEC.
Source:Aug 13, 2026, 07:36 UTC
Ballast Inc. acquired a new stake in Elevance Health, Inc. by purchasing 1,572 shares valued at approximately $608,000, as disclosed in a recent SEC filing.
Source:Jul 15, 2026, 17:12 UTC
Elevance Health announced on its second-quarter earnings call that it plans to further shrink its Medicaid portfolio over the next 12 to 18 months, exiting markets it deems unsustainable.
Source:Jul 15, 2026, 10:28 UTC
Elevance Health declared a quarterly dividend of $1.72 per share, up $0.01 from the prior year.
Source:Jul 15, 2026, 10:00 UTC
Elevance Health reported its second quarter 2026 financial results.
Jul 2, 2026, 18:34 UTC
Elevance Health filed a lawsuit against the U.S. government in the U.S. District Court for the Southern District of Georgia, alleging that federal efforts to recalculate its Medicare Advantage quality ratings did not align with a recent court ruling, costing the insurer $115 million.
Source:Jun 26, 2026, 18:30 UTC
Elevance Health paid $342 million to the U.S. Centers for Medicare & Medicaid Services to settle allegations of overbilling the Medicare Advantage program, following a CMS enforcement action that threatened to halt enrollments.
Source:Jun 25, 2026, 11:30 UTC
CNSide Diagnostics, a subsidiary of Plus Therapeutics, signed a national coverage agreement with Elevance Health to provide the CNSide CSF TCE assay to approximately 45.4 million people in the United States.